• All
  • Executive Search
  • Finance
  • M&A
  • Views

Salt Lake City, UT – August 25, 2020 – DiscGenics, Inc., a clinical stage biopharmaceutical company developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative...

Q1 Revenue of $6.5 Billion Decreased 13% Reported and Approximately 17% Organic Q1 GAAP Diluted EPS of $0.36; Q1 Non-GAAP Diluted EPS of $0.62 DUBLIN, Aug. 25, 2020 (GLOBE NEWSWIRE)...

AUSTIN, Texas--(BUSINESS WIRE)--Wenzel Spine, Inc., a medical technology company focused on providing minimally invasive solutions for the treatment of spinal disorders, today announced that it has completed the acquisition of...